Quantinno Capital Management LP Has $6.53 Million Stock Position in Revvity, Inc. (NYSE:RVTY)

Quantinno Capital Management LP boosted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 33.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,469 shares of the company's stock after purchasing an additional 14,777 shares during the period. Quantinno Capital Management LP's holdings in Revvity were worth $6,526,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its position in shares of Revvity by 16.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after purchasing an additional 2,969,326 shares during the last quarter. Vanguard Group Inc. raised its position in Revvity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock worth $1,594,930,000 after acquiring an additional 156,679 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Revvity by 17.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock valued at $851,764,000 after acquiring an additional 1,151,821 shares during the period. Janus Henderson Group PLC increased its stake in shares of Revvity by 0.4% during the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock worth $709,725,000 after purchasing an additional 23,650 shares during the last quarter. Finally, EdgePoint Investment Group Inc. raised its holdings in shares of Revvity by 51.1% in the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock valued at $452,939,000 after purchasing an additional 1,372,456 shares during the period. Institutional investors own 86.65% of the company's stock.

Revvity Stock Performance

Shares of RVTY traded up $0.43 during mid-day trading on Thursday, hitting $90.26. 426,523 shares of the company's stock were exchanged, compared to its average volume of 947,205. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 52 week low of $88.53 and a 52 week high of $129.50. The stock's 50-day simple moving average is $97.62 and its 200-day simple moving average is $109.81. The firm has a market cap of $10.64 billion, a price-to-earnings ratio of 40.83, a price-to-earnings-growth ratio of 3.82 and a beta of 1.02.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm's quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.98 earnings per share. On average, equities research analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on RVTY. Robert W. Baird cut their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. KeyCorp increased their price target on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Wells Fargo & Company cut their price target on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. reduced their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Finally, Raymond James reissued an "outperform" rating and issued a $120.00 price objective (down from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.